Sarcopenia as a public health problem

被引：42

作者：

Bruyere, O. ^{[1
,2
]}

Beaudart, C. ^{[1
,2
]}

Locquet, M. ^{[1
]}

Buckinx, F. ^{[1
,2
]}

Petermans, J. ^{[3
]}

Reginster, J. -Y. ^{[1
,2
]}

机构：

[1] Univ Liege, Dept Publ Hlth Epidemiol & Hlth Econ, CHU Sart Tilman, B23,13 Ave Hippocrate, B-4000 Liege, Belgium

[2] Univ Liege, Support Unit Epidemiol & Biostat, 13 Ave Hippocrate, B-4000 Liege, Belgium

[3] CHU Liege, Dept Geriatr, 13 Ave Hippocrate, B-4000 Liege, Belgium

来源：

EUROPEAN GERIATRIC MEDICINE | 2016年 / 7卷 / 03期

关键词：

Sarcopenia; Public health; Costs; Epidemiology; Frailty; Treatment; EUROPEAN WORKING GROUP; OLDER-PEOPLE EWGSOP; QUALITY-OF-LIFE; MUSCLE STRENGTH; RISK-FACTOR; VITAMIN-D; PREVALENCE; MORTALITY; ASSOCIATION; DEFINITION;

D O I：

10.1016/j.eurger.2015.12.002

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

030301 [社会学]; 100201 [内科学];

摘要：

The importance of a health problem is based on its current and expected prevalence, its clinical and economic consequences, the social status of people affected by the problem and the availability of an effective treatment. In this paper, we review the main current literature on sarcopenia in order to assess whether this geriatric syndrome could be considered as a major public health problem. Our review highlights that based on its prevalence, its clinical consequences, the limitations of the current available treatments as well as on the fact that many frail patients are affected by this geriatric syndrome, sarcopenia should be considered as a health priority by all interested parties in order to reduce its burden. (C) 2015 Elsevier Masson SAS and European Union Geriatric Medicine Society. All rights reserved.

引用

页码：272 / 275

页数：4

共 45 条

[1]

Mortality as an adverse outcome of sarcopenia [J].

Arango-Lopera, V. E. ;

Arroyo, P. ;

Gutierrez-Robledo, L. M. ;

Perez-Zepeda, M. U. ;

Cesari, M. .

JOURNAL OF NUTRITION HEALTH & AGING, 2013, 17 (03) :259-262

[2]

Quality of life and physical components linked to sarcopenia: The SarcoPhAge study [J].

Beaudart, C. ;

Reginster, J. Y. ;

Petermans, J. ;

Gillain, S. ;

Quabron, A. ;

Locquet, M. ;

Slomian, J. ;

Buckinx, F. ;

Bruyere, O. .

EXPERIMENTAL GERONTOLOGY, 2015, 69 :103-110

[3]

Estimation of sarcopenia prevalence using various assessment tools [J].

Beaudart, C. ;

Reginster, J. Y. ;

Slomian, J. ;

Buckinx, F. ;

Dardenne, N. ;

Quabron, A. ;

Slangen, C. ;

Gillain, S. ;

Petermans, J. ;

Bruyere, O. .

EXPERIMENTAL GERONTOLOGY, 2015, 61 :31-37

[4]

Beaudart C, 2014, J MUSCULOSKEL NEURON, V14, P425

[5]

Beaudart C, 2015, AGE AGEING IN PRESS

[6]

Beaudart C, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-45

[7]

The Effects of Vitamin D on Skeletal Muscle Strength, Muscle Mass, and Muscle Power: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [J].

Beaudart, Charlotte ;

Buckinx, Fanny ;

Rabenda, Veronique ;

Gillain, Sophie ;

Cavalier, Etienne ;

Slomian, Justine ;

Petermans, Jean ;

Reginster, Jean-Yves ;

Bruyere, Olivier .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (11) :4336-4345

[8]

Bruyère O, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-32

[9]

Sarcopenia and malnutrition in acutely ill hospitalized elderly: Prevalence and outcomes [J].

Cerri, Anna Paola ;

Bellelli, Giuseppe ;

Mazzone, Andrea ;

Pittella, Francesca ;

Landi, Francesco ;

Zambon, Antonella ;

Annoni, Giorgio .

CLINICAL NUTRITION, 2015, 34 (04) :745-751

[10]

Cesari, Matteo ;

Rolland, Yves ;

Van Kan, Gabor Abellan ;

Bandinelli, Stefania ;

Vellas, Bruno ;

Ferrucci, Luigi .

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2015, 70 (04) :457-463

← 1 2 3 4 5 →